R03TR004193
Project Grant
Overview
Grant Description
Hepatic GPR125: Ligands and Liver Repair - Project Summary
G protein-coupled receptors (GPCRs) are 7 transmembrane domain proteins that aid in the maintenance of homeostasis by responding to cues produced by the internal and external environment. In humans, there are more than 800 known GPCRs, and while more than 20% of all FDA-approved drugs target GPCRs, the vast majority of these receptors are understudied.
In fact, many of these uncharacterized 'orphan' receptors, termed GPRs, are expressed at extremely high levels in different tissues suggesting that they likely have important, yet unknown, physiological functions. The liver is the largest metabolic tissue in the human body and is responsible for a number of important functions including sensing and detoxifying xenobiotics, metabolizing glucose and other energy sources, and synthesizing and secreting bile acids. Thus, it is well-poised to take advantage of some sensory GPRs to aid in these processes.
We recently identified a total of 57 GPRs that are expressed to varying degrees in the murine liver, including 7 with expression profiles that rival other well-characterized receptors. One of these high expressing receptors is adhesion receptor GPR125 (ADGRA3). As a family, adhesion receptors have been linked to the maintenance of cell-cell junctions and have been reported to be activated by proteolytically cleavage of their non-covalently attached N-terminal domain. However, GPR125 is an atypical adhesion receptor with a mutated cleavage site and it is unclear if this receptor is activated via the conventional processes.
GPR125 has been linked to the development of planar cell polarity in a zebrafish model suggesting that this receptor may be involved in tissue repair in adult tissues. Using RNASCOPE and immunofluorescence, we have localized GPR125 to the basolateral membrane of cholangiocytes. Lining the bile ducts, cholangiocytes play a key role in liver regeneration following injury. Thus, GPR125 is uniquely suited to contribute to this process.
We hypothesize that GPR125, on the basolateral membrane of cholangiocytes, is activated by components of the extracellular matrix in order to contribute to liver repair following injury. This will be tested using the PRESTO-TANGO assay to deorphanize the receptor alongside a unique liver-specific knockout mediated by adenoviral delivery of CRISPR guide RNAs. Collectively, our discoveries will unveil new functions for a highly expressing, yet under-characterized, receptor and will set the stage for future physiological analysis in both mouse and man.
G protein-coupled receptors (GPCRs) are 7 transmembrane domain proteins that aid in the maintenance of homeostasis by responding to cues produced by the internal and external environment. In humans, there are more than 800 known GPCRs, and while more than 20% of all FDA-approved drugs target GPCRs, the vast majority of these receptors are understudied.
In fact, many of these uncharacterized 'orphan' receptors, termed GPRs, are expressed at extremely high levels in different tissues suggesting that they likely have important, yet unknown, physiological functions. The liver is the largest metabolic tissue in the human body and is responsible for a number of important functions including sensing and detoxifying xenobiotics, metabolizing glucose and other energy sources, and synthesizing and secreting bile acids. Thus, it is well-poised to take advantage of some sensory GPRs to aid in these processes.
We recently identified a total of 57 GPRs that are expressed to varying degrees in the murine liver, including 7 with expression profiles that rival other well-characterized receptors. One of these high expressing receptors is adhesion receptor GPR125 (ADGRA3). As a family, adhesion receptors have been linked to the maintenance of cell-cell junctions and have been reported to be activated by proteolytically cleavage of their non-covalently attached N-terminal domain. However, GPR125 is an atypical adhesion receptor with a mutated cleavage site and it is unclear if this receptor is activated via the conventional processes.
GPR125 has been linked to the development of planar cell polarity in a zebrafish model suggesting that this receptor may be involved in tissue repair in adult tissues. Using RNASCOPE and immunofluorescence, we have localized GPR125 to the basolateral membrane of cholangiocytes. Lining the bile ducts, cholangiocytes play a key role in liver regeneration following injury. Thus, GPR125 is uniquely suited to contribute to this process.
We hypothesize that GPR125, on the basolateral membrane of cholangiocytes, is activated by components of the extracellular matrix in order to contribute to liver repair following injury. This will be tested using the PRESTO-TANGO assay to deorphanize the receptor alongside a unique liver-specific knockout mediated by adenoviral delivery of CRISPR guide RNAs. Collectively, our discoveries will unveil new functions for a highly expressing, yet under-characterized, receptor and will set the stage for future physiological analysis in both mouse and man.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
District Of Columbia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/23 to 12/31/24.
Georgetown University was awarded
Project Grant R03TR004193
worth $156,000
from the National Institute of Allergy and Infectious Diseases in June 2022 with work to be completed primarily in District Of Columbia United States.
The grant
has a duration of 2 years 6 months and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Project Grant was awarded through grant opportunity Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 8/20/24
Period of Performance
6/1/22
Start Date
12/31/24
End Date
Funding Split
$156.0K
Federal Obligation
$0.0
Non-Federal Obligation
$156.0K
Total Obligated
Activity Timeline
Transaction History
Modifications to R03TR004193
Additional Detail
Award ID FAIN
R03TR004193
SAI Number
R03TR004193-3489938217
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
TF2CMKY1HMX9
Awardee CAGE
0UVA6
Performance District
DC-98
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $156,000 | 100% |
Modified: 8/20/24